Τρίτη 9 Οκτωβρίου 2018

Clinical efficacy of tacrolimus for treating myasthenia gravis and its influence on lymphocyte subsets.

CONCLUSION: A relatively low dose of tacrolimus can affect multiple immune-system targets and, thus, can treat MG effectively in terms of both clinical symptoms and immunological responses. PMID: 30293884 [PubMed - as supplied by publisher] (Source: Revue Neurologique)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.



from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Oc14Tr

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.